Search
for
Sort by
Research 91–120 of 655
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- PCOS and Obesity: Contraception Challenges
- Prescription Appropriateness of Cyproterone Acetate/Ethinylestradiol in Primary Care: A Population-Based Study in Italy
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- EFFECTS OF HORMONAL THERAPY IN TRANSGENDERS
- Complications associated with oncological therapy - how to minimize?
- ALOPECIA AREATA
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
- PRP and Microneedling in Aesthetic Medicine
- Eczema-like, erythematous, infiltrated plaques: A common side effect of subcutaneous heparin therapy
- Hypersensitivity Reactions to Anticoagulant Drugs
- Prospective metabolic evaluation of 150 consecutive patients who underwent gastric exclusion
- Topical imiquimod—Be aware of the unexpected
- A case of widespread actinic granuloma with associated drug-induced lupus erythematosus
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- The Rotterdam Study: 2016 objectives and design update
- Prevalence of polycystic ovary syndrome in women in China: a large community-based study
- Acne
- COVID-19 and Sex Differences
- Testosterone therapy for transgender men
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Hormonal treatment of acne vulgaris: an update
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Evidence-based approach to cutaneous hyperandrogenism in women
- Update on the dermatologic use of systemic glucocorticosteroids
- Anabolic-androgenic steroids and cardiovascular risk